1.01
1.01 (-6.74%)
As of Mar 06, 2024
Sangamo Therapeutics, Inc [SGMO]
Source:
Company Overview
We are a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious diseases. We plan to deliver on this mission through development of our clinical and preclinical product candidates leveraging our novel science and our in-house manufacturing capabilities.
Country | United States |
Headquarters | brisbane, california |
Phone Number | 5109706000 |
Industry | manufacturing |
CEO | Alexander D. Macrae |
Website | www.sangamo.com |